Ashokan, Rajeev – Trademark Portfolio

Entity Type: 01

Ashokan, Rajeev holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 24 (Fabrics) — 3 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REYMEY. The owner is based in hackensack, NJ.

344b dewolf place

hackensack, NJ 07601

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #97860501
Registered 2023
REYMEY
REYMEY
Registered 2019
ROYSHA
ROYSHA
Cancelled 2017
ROYSHA
ROYSHA
Cancelled 2017

Trademark Classifications

Ashokan, Rajeev's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (3 filings)

Textiles and textile goods; bed covers; table covers

25
Clothing (2 filings)

Clothing, footwear, headgear

18
Leather Goods (2 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Ashokan, Rajeev have?

Ashokan, Rajeev has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does Ashokan, Rajeev file in?

Ashokan, Rajeev files trademarks across 3 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 25 (Clothing), Class 18 (Leather Goods). Class 24 covers textiles and textile goods; bed covers; table covers.

What are Ashokan, Rajeev's most well-known trademarks?

Ashokan, Rajeev's registered trademark portfolio includes well-known marks such as REYMEY. These are among 2 currently registered trademarks in the portfolio.

What is Ashokan, Rajeev's trademark registration success rate?

Ashokan, Rajeev has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.